Literature DB >> 3426836

Neuropsychological studies on adolescents with phenylketonuria returned to phenylalanine-restricted diets.

J T Clarke1, R D Gates, S E Hogan, M Barrett, G W MacDonald.   

Abstract

Nine adolescents with phenylketonuria (PKU), who had been on unrestricted diets for 2 to 11 years, underwent serial neuropsychological testing over two consecutive 4- to 5-week periods during which each was maintained on a low-phe diet supplemented in a triple-blind fashion either with L-phe (high phe) or L-alanine (low phe). Assignment to the initial condition was done randomly, and the alternate condition was substituted at the end of the first 4- to 5-week period. In 6 of 7 subjects with PKU, baseline median choice reaction times (RTs) were slower than those of controls matched for age, sex, handedness, and Full-Scale IQ (WISC-R). A highly significant improvement occurred during the low-phe phases of the study. Results suggest that adolescents with PKU on unrestricted diets have a neuropsychological deficit that is out of proportion to their overall intellectual handicap. Moreover, this deficit appears to be at least partly reversible by return to dietary phe restriction despite years of hyperphenylalaninemia.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3426836

Source DB:  PubMed          Journal:  Am J Ment Retard        ISSN: 0895-8017


  12 in total

1.  Preliminary neuropsychological test results.

Authors:  L M de Sonneville; E Schmidt; U Michel; U Batzler
Journal:  Eur J Pediatr       Date:  1990       Impact factor: 3.183

2.  Randomised controlled trial of tyrosine supplementation on neuropsychological performance in phenylketonuria.

Authors:  M L Smith; W B Hanley; J T Clarke; P Klim; W Schoonheyt; V Austin; D C Lehotay
Journal:  Arch Dis Child       Date:  1998-02       Impact factor: 3.791

3.  Effects of concurrent phenylalanine levels on sustained attention and calculation speed in patients treated early for phenylketonuria.

Authors:  E Schmidt; P Burgard; A Rupp
Journal:  Eur J Pediatr       Date:  1996-07       Impact factor: 3.183

Review 4.  A prefrontal dysfunction model of early-treated phenylketonuria.

Authors:  M C Welsh
Journal:  Eur J Pediatr       Date:  1996-07       Impact factor: 3.183

Review 5.  The truth of treating patients with phenylketonuria after childhood: the need for a new guideline.

Authors:  F J van Spronsen; P Burgard
Journal:  J Inherit Metab Dis       Date:  2008-08-12       Impact factor: 4.982

Review 6.  Dietary interventions for phenylketonuria.

Authors:  Vanessa J Poustie; Joanne Wildgoose
Journal:  Cochrane Database Syst Rev       Date:  2010-01-20

7.  Insurance coverage of special foods needed in the treatment of phenylketonuria.

Authors:  B N Millner
Journal:  Public Health Rep       Date:  1993 Jan-Feb       Impact factor: 2.792

8.  Information processing in patients with early and continuously-treated phenylketonuria.

Authors:  B A Stemerdink; J J van der Meere; M W van der Molen; A F Kalverboer; M M Hendrikx; J Huisman; L W van der Schot; F M Slijper; F J van Spronsen; P H Verkerk
Journal:  Eur J Pediatr       Date:  1995-09       Impact factor: 3.183

9.  Dietary interventions for phenylketonuria.

Authors:  Elisabeth Jameson; Tracey Remmington
Journal:  Cochrane Database Syst Rev       Date:  2020-07-16

10.  Alanine prevents the reduction of pyruvate kinase activity in brain cortex of rats subjected to chemically induced hyperphenylalaninemia.

Authors:  Luciane Rosa Feksa; Andrea Renata Cornelio; Virginia Cielo Rech; Carlos Severo Dutra-Filho; Angela Terezinha Souza Wyse; Moacir Wajner; Clóvis Milton Duval Wannmacher
Journal:  Neurochem Res       Date:  2002-09       Impact factor: 3.996

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.